Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026)
Biocryst Pharmaceuticals' (BCRX) quarterly Total Debt came in at $435.5 million in Q1 2026, up 24.53% YoY from $349.7 million in Q1 2025, and up 1032.53% on a QoQ basis from $38.5 million in Q4 2025.
Biocryst Pharmaceuticals (BCRX) Total Debt (2011 - 2026) Analysis & Trends
Biocryst Pharmaceuticals (BCRX) has 16 years of Total Debt data on file, last reported at $435.5 million in Q1 2026.
- Quarterly Total Debt rose 24.53% year-over-year to $435.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $435.5 million (up 24.53% YoY) and the FY2025 annual result came in at $38.5 million, down 88.94% from the prior year.
- Total Debt grew to $435.5 million in Q1 2026, from $38.5 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $435.5 million in Q1 2026 to a low of $38.5 million in Q4 2025.
- A 5-year average of $270.4 million and a median of $293.2 million in 2023 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt soared 102.87% — and 2025, when it sank 88.94%.
- Tracing BCRX's Total Debt over 5 years: stood at $231.6 million in 2022, then surged by 41.09% to $326.8 million in 2023, then climbed by 6.35% to $347.5 million in 2024, then slumped by 88.94% to $38.5 million in 2025, then surged by 1032.53% to $435.5 million in 2026.
- The last three Total Debt figures came in at $435.5 million (Q1 2026), $38.5 million (Q4 2025), and $232.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.82 Bn | 40.16 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 32.64 Bn | 30.96 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.88 Bn | 17.99 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 760.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.11 Bn | 214.41 Mn | 439.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 439.21 Mn |
| Mar 31, 2026 | 435.51 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 232.05 Mn |
| Jun 30, 2025 | 278.54 Mn |
| Mar 31, 2025 | 349.72 Mn |
| Dec 31, 2024 | 347.55 Mn |
| Sep 30, 2024 | 347.33 Mn |
| Jun 30, 2024 | 342.80 Mn |
| Mar 31, 2024 | 334.51 Mn |
| Dec 31, 2023 | 326.80 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 293.18 Mn |
| Mar 31, 2023 | 232.52 Mn |
| Dec 31, 2022 | 231.62 Mn |
| Sep 30, 2022 | 223.87 Mn |
| Jun 30, 2022 | 144.52 Mn |
| Mar 31, 2022 | 140.24 Mn |
| Dec 31, 2021 | 298.14 Mn |
| Sep 30, 2021 | 132.05 Mn |